Trump Trade: GoodRx, others in talks with White House to join TrumpRx

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly:

TRUMPRX: Retail pharmacies and prescription drug savings site GoodRx (GDRX) are in discussions with the Trump administration about joining its TrumpRx website, indicating an expansion beyond the early description of it as a link to drugmakers’ direct discounts, Reuters’ Deena Beasley reports. Pharma companies, including Pfizer (PFE) and Amgen (AMGN) are offering to sell some brand-name medicines directly to consumers at the negotiated prices they get from insurers, the author says. Some say they plan tot work with TrumpRx, driven in part by President Trump’s threats of harsh tariffs on drugmakers that don’t lower prices and boost U.S. manufacturing, the author says, noting the site is due to launch in 2026. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).

Commenting on Reuters’ news, BofA highlights that the firm doesn’t have “a strong view at this time” on the potential upside/downside from TrumpRx. The Trump administration is putting immense pressure on manufacturers and PBMs to shift completely away from list prices and toward net prices and “the popping of the gross to net bubble is a negative for GoodRx’s original business model,” the analyst tells investors. The firm, which argues that GoodRx’s future success will depend on its ability to navigate this “rapidly evolving market,” maintains an Underperform rating on GoodRx shares.

NASA: Shift4 Payments (FOUR) executive chairman Jared Isaacman and President Trump have met in recent weeks to discussed Isaacman’s potential revived nomination to lead NASA, Ed Ludlow, Loren Grush and Jennifer Dlouhy of Bloomberg report, citing person familiar with the matter. The person cautioned that Trump hasn’t made a final decision, Bloomberg adds.

TP-LINK RESTRICTIONS: Shares of Netgear (NTGR) moved higher after Bloomberg reported that the Trump administration is considering placing restrictions on the U.S. operations of TP-Link Systems, a maker of routers. The White House may to take action against TP-Link, saying it poses a national security threat following an investigation into its China ties, people familiar with the matter told Bloomberg.